IceCure Medical Ltd. (Nasdaq: ICCM) has published results of an independent study demonstrating safety and efficacy of its ProSense® System. The study, published in the…
December 05, 2023
December 04, 2023
Alterity Therapeutics Shows Positive Efficacy in Parkinson’s Disease Treatment; Shares Surge 160%
Alterity Therapeutics (Nasdaq: ATHE) has presented promising new data on the effect of ATH434 in a Parkinson’s disease primate model at the Future of Parkinson’s…
December 04, 2023
Biotech Breakfast – Healthcare Equities Close Higher, Major Healthcare Groups Fare Well; Altimmune Soars while Pfizer Falls on Obesity Clinical Updates
Healthcare equities closed higher on Friday afternoon, with most major healthcare groups faring well. Healthcare closed up +0.11% versus the S&P 500 which rose +0.54%….
MIRA Pharmaceuticals (Nasdaq: MIRA) has released new data from artificial intelligence (AI) simulations showing that there may be significant potential advantages to the therapeutic potential…
December 01, 2023
Biora Therapeutics Offers Hope to 1.8 Million Americans with Inflammatory Bowel Disease
Biora Therapeutics (Nasdaq: BIOR) has received FDA clearance for its Investigational New Drug (IND) application for BT-600, a drug/device combination for the treatment of moderate…
December 01, 2023
Positive Topline Results for Altimmune in Obesity Drug Trial; Shares up 41% in Morning Trading
Altimmune, Inc. (Nasdaq: ALT) has reported positive topline results from its 48-week MOMENTUM Phase 2 obesity trial of pemvidutide. Over 50% of subjects achieved at…
Abeona Therapeutics (Nasdaq: ABEO) has been granted Priority Review for its Biologics License Application (BLA) for pz-cel (prademagene zamikeracel), the company’s investigational autologous, COL7A1 gene-corrected…
November 30, 2023
Biodexa Asset Offers Potential to ‘Radically Improve’ Treatment for Diabetes Patients
Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) has entered into an agreement for the rights to develop and commercialize tolimidone under an exclusive, worldwide license from Melior…
November 29, 2023
Vivos Therapeutics Receives FDA Approval for Oral Sleep Apnea Device; Shares Skyrocket 270%
Medical device and technology company, Vivos Therapeutics (Nasdaq: VVOS) has been granted 510(k) clearance by the FDA for treating severe obstructive sleep apnea (OSA) in…
November 29, 2023
Department of Defense to Study Seelos Therapeutics’ Ketamine Compound as PTSD Treatment
Seelos Therapeutics, Inc. (Nasdaq: SEEL) has announced that its drug candidate, SLS-002 (intranasal racemic ketamine), has been selected for inclusion in a clinical trial to…
November 28, 2023
Scisparc Using Psychedelics to Target Weight Loss
Scisparc Ltd. (Nasdaq: SPRC) has achieved positive results in a preclinical trial observing the safety and impact of a combination treatment on various metabolic and…
November 27, 2023
Redhill Biopharma Granted 5-Year Market Exclusivity for Antibiotic Treatment; Shares Surge 243%
Redhill Biopharma (Nasdaq: RDHL) has been granted five years’ market exclusivity for Talicia under the Generating Antibiotic Incentives Now (GAIN) Act Qualified Infectious Disease Product…